TOKYO -- Japan needs a "drug discovery ecosystem" so that it can more efficiently turn its scientific discoveries into effective medicines, Osamu Okuda, president and CEO of Chugai Pharmaceutical, said Tuesday.
Swiss drug maker Roche Group holds a stake of just under 60% in Chugai.
